Effect of L‐Dopa on Polycythemia

Y. Herishanu, P. Rosenberg

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A patient with Parkinson's disease, in whom polycythemia vera was known to be present for several years prior to the onset of parkinsonian symptoms, received treatment with a preparation consisting of L‐dopa plus a decarboxylase inhibitor (Madopar). Improvement in the parkinsonian symptoms was associated with marked improvement in the polycythemia. A therapeutic trial of the same L‐dopa preparation in 2 other patients with polycythemia had similar effects. The cases are presented and the possible central therapeutic effect of L‐dopa is discussed.

Original languageEnglish
Pages (from-to)218-219
Number of pages2
JournalJournal of the American Geriatrics Society
Volume25
Issue number5
DOIs
StatePublished - 1 Jan 1977
Externally publishedYes

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Fingerprint

Dive into the research topics of 'Effect of L‐Dopa on Polycythemia'. Together they form a unique fingerprint.

Cite this